Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
McKesson
AstraZeneca
Mallinckrodt
McKinsey

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Masitinib

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Masitinib: Sponsors, patents, clinical trial progress

Masitinib is an investigational drug.

There have been 30 clinical trials for Masitinib. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2008.

The most common disease conditions in clinical trials are Gastrointestinal Stromal Tumors, Sclerosis, and Recurrence. The leading clinical trial sponsors are AB Science and [disabled in preview].

Recent Clinical Trials for Masitinib
TitleSponsorPhase
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsAB SciencePhase 3
Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil LevelsAB SciencePhase 3
Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal CancerAB SciencePhase 2/Phase 3

See all Masitinib clinical trials

Clinical Trial Summary for Masitinib

Top disease conditions for Masitinib
Top clinical trial sponsors for Masitinib

See all Masitinib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Colorcon
Dow
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.